Reddit Posts
Jazz Pharma, Zymeworks post 84% overall survival for cancer candidate (NASDAQ:JAZZ)
Cannabis Is The New Pharma Gold | Martin Shkreli Analyses $JAZZ -Jazz Pharmaceuticals Stock [Q4 2022]
Wondering if my buy instinct is good on Jazz Pharma. (Asking for any confirmation or second opinions, details below)
$JAZZ (Jizz Pharmaceuticals): Curing Your Autism With Weed 420 DD
UCB to acquire Zogenix $ZGNX for $1.9 billion, Bright Minds Biosciences' ($DRUG )BMB-101 for the same indication to hit clinical trials in a couple of months
Luvox may help treat Covid. I’m betting JAZZ price will increase. I can only afford 3 shares but that’s my bet.
I was holding a couple of cannabis stocks that are no longer untradable. Anything I can do?
Best short term investment I have seen in a long time. $SLS 🚀🚀🚀
FDA Approves Component of Treatment Regimen for Most Common Childhood Cancer - JAZZ PHARMACEUTICALS
Any thoughts on getting free stocks without refferals?
My Watchlist for 4/28/2021 -- Bruce Swingsteen Is In The House
My Watchlist For 3/30/21 -- Focus Healthcare, Utilities, and Real Estate
If you're are still confused... you're not paying attention. GME
Mentions
Ah yes, I see it now as JAZZ. Thanks. It would have been easier and more efficient for you to just provide name in the first place. I don’t assume anything. Wonder what your glitch is Geo.
JAZZ flying today - Canadian side.
GTBIF TCNNF CURLF JAZZ a pharmaceutical company that has several marijuana based drugs.
Next truth: I AM GOING TO CANCEL ALL TARIFF. TARIFF ARE BAD, VERY BAD, THE BADDEST. IT IS THE UGLIES WORD I HAVE EVER KNOWN. I HATE THAT WORD. SLEEPY JOE LOVE THAT WORD, I DON'T. (JAZZ HAND). CHYNA HAS SUBSIDIZE US FOR 5 TRILLION DOLLAR A MONTH, XI IS ONE OF MY BEST FRIEND, ONLY SECOND TO PUTIN AND KIMMY.
Pharma? JAZZ is on track to post $24 in earns yet trades for 138-140? What is wrong with this company? CPRX revenue growth? BMY for diva and oncology. Snoozers for sure. But not down 12%!
Defense Defense GILD! Defense Defense JAZZ! Defense Defense CPRX! Defense Defense NVO! Defense Defense DVAX!
Better jump on that bandwagon quickly. GRAL, DGX, JNJ, CVS, JAZZ are all great picks in the healthcare and consumer staples sector. I just bought GOLD (Barrick), based on how it’s near the bottom, posting increasing profits, and moving forward with a stock buyback program. I disagree with your assessment that gold is overbought. I think it is the opposite. If you have an open mind to other commodities, energy is a great choice, including uranium. I have also bought LIT, and would be okay with oil.
> I think most people in here agree, over the long term, weed companies will make money and stock prices will reflect that, but I’m sure we would also agree that right now, it’s volatile. I am not so sure. I am here for the uplisting, and then I am getting out. These companies don't have any IP and they don't do anything unique. I can't predict which branding campaigns will be successful and even then I don't think the long term margins in this sector are going to be that different than any other agricultural product. There might be outliers like JAZZ or other pharmaceutical companies that are able to develop medication that they own, but this will be no different than investing in any other biotech or pharm company, ie most will fail and predicting the winners is nigh impossible. The money, at least in my opinion, will be made when these companies are able to uplist and then it's a race to the bottom again.
Congrats degens, GRND price, avg. vol., and avg. option vol. is UP 📈 (relative to time of day)...slightly, which isn't saying much...but hey, it's a start. JAZZ HANDS 👐 LFG! 🌈💰
Not me, but my dad. I remember when he bought about 10,000 shares of JAZZ for $1 each and sold at $6. He was super excited about his great return. Now JAZZ is about $111
Bro this is the only way though unfortunately if you like dat good JAZZ CABBAGE, anyone claiming they have street weed better is just a liar, scam artist, or delusional
Exel - purchase avg 1.67 sold a lot at 30, still holding a few thousand shares. Gwph - bought bunch at 8, held until buyout from JAZZ at like 215
Pretty irrelevant imo. Cannabis will be still grown and consumed. When Philip Morris buys out JAZZ and starts producing Epidiolex and starts making other Cannabjs based FDA approved medications how would that affect the Cannabis industry at all?
JAZZ dabbles in cannabinoid meds
There are a few that claim to be doing research or pursuing FDA approval for cannabinoid based drugs and treatments, but the only really legit company I can think of is GW Pharma that was bought by JAZZ.
I’m interested but I don’t understand, are you investing in SEEL or JAZZ?
Jazz Pharmaceuticals (JAZZ) would my personal safest bet to benefit from rescheduling of cannabis. Currently the price premarket is $136.40. My high risk high reward bet would be on Tilray (TLRY) and that is basically because of how low the price is right now ($3.02 as premarket today) and how big of a presence they currently have in the US market. But that’s just like my opinion man lol 😂
charlotte's web is the best play at this point--developing a drug with BAT. the other one was GW Pharma and got bought by JAZZ years ago.
But my JAZZ calls are gonna print tho right? Please don't hurt me Mr. Market. I'll be a good regard, I promise.
More mature biotech companies that have a robust pipeline and are already fairly discovered may be the way to go I like ARWR and ALNY for that reason. JAZZ too I used to own DRNA. Got acquired at premium. That's a best-case scenario often. Also HZNP Again, not 100x gains. Maybe 2x. And that's a okay.
I'm heavy on TRKA but I'm also playing ADVL. Patent lawsuit seems to be resolved with JAZZ and outcome in the favor of AVDL. Soon after hoping the FDA approval is out. Great potential. I don't cross spam but I thought if everyone is trying to make money at least put it out there and let others decide. Either way GLTA and I hope you guys make money anywhere you put your bags. Not financial advice.
https://www.macrotrends.net/stocks/stock-comparison?s=eps-earnings-per-share-diluted&axis=single&comp=VIR:ALNY:JAZZ:APLS:SRP This is where I spend most my time comparing $Vir with other big companies some worth +25b valuation and incredibly Vir has better Shareholder equity than all of these companies yet has the lowest share price. Check out the other metrics that can be used such as Revenue, Cash on Hand, Earning Etc. $Vir is mostly #1 out of the 5
The data so far!! There is topline data imminent (before year end) which may trigger a 1.6billion dollar deal with JAZZ pharmaceuticals!!!
Very similar to ZYME. Stock just had breast cancer readout very similar to AMAM. More data expected within 20 days. With 1.6 billion agreement with JAZZ pharma. $30 stock soon
This has implications for other markets as well Look into Jazz Pharma (JAZZ) - they acquired GW Pharma a year or two ago who were a major European player in canabanoid therapies. Probably some other pharma companies out there who could benefit as well Everyone is understandably focusing on the recreational side of things but there is BIG fucking money to be made if cannabis gets rescheduled (which signs suggest it will)
Already happening with big pharma; JAZZ is a good example
I was able to locate some US companies, some of which are OTC. I will add these to the list. CRLBF TRSSF TCNNF VRNOF VFF GTBIF IIPR GWRG SMG JAZZ I was trying to avoid OTC but they are worth investigating and could end up being listed in the majors.
$JAZZ Look at that sexy intellectual property they have :)
Fully committed PIPE of $162 million led by $100 million from Social Capital with remaining $62 million from new and existing investors including: Suvretta Capital Management’s Averill strategy, Apeiron Investment Group, Temasek, co-founder PureTech Health, Polaris Partners, Evidity Health Capital, JAZZ Venture Partners and Omidyar Technology Ventures" ​ Source: https://www.socialcapitalsuvrettaholdings.com/dnaa
That would be $TEVA and $JAZZ tbh
Everyone says TEVA but my thesis for TEVA is also that long covid will turn out to be narcolepsy or adjacent to it - I have narcolepsy FYI - and TEVA and JAZZ male a lot of the stuff that would be useful for it.
[Unc D presents ‘MUMBLE JAZZ’ Live at Beachland Ballroom (ft. Nathan- Paul Davis)](https://www.youtube.com/watch?v=0hKU9S9D7GI&ab_channel=UncD)
AXSM ahead of long weekend. AXS 05 expected to get approval before April 30 date for second drug, AXS 07. Company will likely have three FDA approved drugs in this month after the purchase of Sunosi from JAZZ, a billion dollar drug, for only $59 million up front plus roayalties. AXSM is a $350 stock, in 2024, trading at $39.00 today after all four drugs, AXS 05, 07, 12 and 14 get approved this year and next.
Investing in weed was always an L for me. $JAZZ is the way.
I think we will just have to agree to disagree. JAZZ is also 3 times the size of CGC and CGC can still appeal the ruling.
Some of you morons laughed at my $JAZZ (JIZZZ PHARMA) DD. This is a great fucking buy, the intellectual property on cannabinoid drugs is strong and is being exercised. ​ **BULLISH** $JAZZ
Certain Drs. still perscribe it; but its **nothing** like it used to be. DEA keeps it in real check, most doctors know to act right unless theres good medical need. Some dr still just get silly with it which is pretty irresponsible. Got a family friend whos a pain mgmt doctor who doesn't know jack fuck all about addiction, which is curious. Pain pill mills have been dying out, but there's probably still some operating locally in places. I don't have an ear to the streets like I used too. AAC used to be the company to short years ago but went belly up. I like JAZZ for controlled substances/unethical pharma plays. They make their $ selling GHB and aquired a GW Pharma recently which is a big weed play
GWPH turned into JAZZ. I haven't touched them in years, but I'm sure it'll pop back up at some point. 5y chart looks like shit, but at least it's holding above 2018 support. Currently valued at $7.6b. GWPH was bought for $7.2b in February at a 50% premium. Epidiolex does around $500m in sales annually. Tetra is a pure lotto play. I got out of them after the constant PR fluff started to annoy me lol
We should talk about weed stocks, CGC, JAZZ, SNDL, TLRY and future European and US legalisations. This thing is not over
$JAZZ Truly beat earnings on both sides and went up less than 3%. Wall Street hates that stock.
JAZZ isn't even on my radar until the Canopy lawsuit is settled. GRWG and HYFM I'll ignore while people can but the exact same stuff on Amazon, only cheaper.
Are you guys buying more stocks right now whilst some are low? Namely: - JAZZ Jazz Pharmaceuticals - SMG Scott's Miracle Gro - AMRS Amhyris - GRWG GrowGeneration - ARNA Arena Pharmaceuticals - HYFM Hydrofarm holdings ^ These make up almost 70% of FLWR Rize Medical Cannabis & Life sciences ETF, which has been loosing value consistently for the past few months. Seriously considering buying more whilst it is low, what do you guys think? (I'm on the LSE so can't get many cannabis stocks)
Tesla IPOd at 2 billion IIRC. How many companies these days are IPOing at that market cap today? This is important in terms of sheer compounded returns from time of investment. UPST wasn't even that low but comes close to one that exploded from that range (ish). Even stocks that are speculative and with minimal revenue but huge potential and a pedigree of sorts like DNA come onto the market with a huge and arguably bloated market cap If you want sheer returns, looking for a company that has a large TAM or one that can expand and a more manageable market cap can ensure bigger returns over time. That said, market cap bias is a real thing. I expect there to be many trillion dollar companies in the next decade. So when, say, INMD hits 100 billion, not much to be alarmed about if the entire market has grown in market cap. INMD is a great bet, by the way. Continues to execute amazingly well and expand into new sectors. Reminds me of ALGN. Another thing is to look at TAMs themselves that will expand. Software for instance makes entirely new markets and that's why it eats the world and took so many by surprise. Apple made a whole new mobile economy with apps, ad tech, Lyft/Uber...possible. MDB is just a database company, for instance. Who cares? Well, people found uses for it, use the product, and the company makes money. Boom, TAM made with MDB the leader. And look at TAMs that encroach on or eat away at incumbents, fintech being the classic example. Biotechs are the other area where stocks can go from 1 dollar to a 1000 over a decade. Hard game to play. JAZZ for instance delivered those returns. IDXX has been extremely successful. ENPH is a solar company that produced a unique product and has amazing management, making its returns over the past decade possible. Right now, I am intrigued by a ticker that stands for "anti tumor necrosis factor" (the initials); look at the research, scientists, TAMs of the drugs, and past successes. At 200 million market cap, nothing is baked into the share price. SDGR and ABCL are biosimulation companies that have huge possible TAMs and a unique revenue generating model -- people see big potential and possibility there. Still, TSLA is a social phenomenon. It's not a company anymore. To understand it, look up how "mimetics" (where the term "memes" comes from) have taken over the market. Explains at least a little of the TSLA phenomena, and more recently UPST
Build a basket to play the different segments of cannabis. I own SMG, IIPR, GTBIF, CRLBF, and GRWG. I used to own GWPH as well before they were bought out by JAZZ. Ergo, buy Jazz if you want a piece of CBD treatments in epilepsy.
You should receive cash and maybe share(s) of JAZZ. Not sure if they will give you a fraction of a share of JAZZ or if you own enough to receive a full share. Deal terms below: Under the terms of the agreement, holders of GW ADSs, which each represented 12 GW ordinary shares, will be entitled to receive $220.00 for each GW ADS, consisting of $200.00 in cash and $20.00 in Jazz ordinary shares. The number of Jazz ordinary shares received per GW ADS is 0.12036, based on the volume weighted average price of Jazz ordinary shares on Nasdaq for the 15 consecutive trading day period beginning on the 18th trading day immediately preceding the closing date of the transaction. Holders of GW ordinary shares that are not in ADS form will be entitled to receive the foregoing consideration divided by 12 per GW ordinary share.
And whats happened to it now? Can I buy this amazing investment? I'll take it off your hands. Ah God. JAZZ beat me to it and is now 25% below its all time high. Must be a great time to buy the dip or something.
How do people write such stupid comments without doing any research? You’re out here trying to act all smart and knowledgeable and failing miserably GWPRF was GW Pharmaceuticals, a company that brought to mark Epidiolex, the first FDA-approved drug derived from CBD, to treat seizures. 2020 sales were expected to be ~$550MM, beset double what 2019 brought in. JAZZ bought GW for a 50% at the time.
If you’re “putting it away for later,” Roth IRA is the right thing. “In it for three months” and “i out it all on (anything other than index funds)” is so, so wrong. With that kind of timeline, you’re gambling. Which is fine. But Roth IRA is probably the wrong vehicle. If you don’t have a retirement account, sell your JAZZ and use those funds to buy some VOO or VTI or QQQ or other “boring/safe” advice here that will make you rich. Keep contributing to that. If you want to gamble in the shorter term, use a normal brokerage account and be honest with yourself about what you’re doing.
JAZZ about to soar
Best play for Cannabis is TCNNF, but GTBIF, JAZZ & SMG are pretty safe ones.
What about $JAZZ and $GUMBO stonks?
JAZZ get FDA approval last night on Xywav sleep disorder drug and it just goes down. Lame.
$JAZZ pharmaceuticals got fda approval today, going to pump soon!!!
Anybody catching the JAZZ knife down here?
JAZZ Pharma just landed FDA approval for Xywav a minute ago. Headed upward
JAZZ pharma today with fda 🚀🚀
JAZZ pharma incoming FDA decision tomorrow 🚀🚀🚀
Such a very very very specific drug, ya think that it really will help with JAZZ whom I thought primarily was just legal weed?
JAZZ got approval for its drug EPIDYOLEX for the treatment of seizures due to tuberous sclerosis today and is massively oversold - I see a rebound. Long 200 shares.
JAZZ pharmaceuticals this morning got approval for product use in UK, announced partnership with cancer organization and has pending FDA approval on Thursday. Could be a real rock ship 🚀
Seems like $JAZZ is due to go back up
I like that JAZZ is profitable and has a deep pipeline. Plus Epidiolex is FDA and EU approved. Will pick up a little this AM and if it goes down some more, will pick up more then. ZYNE will have to raise capital or sell within a year based on their current cash level and is still seeking initial approval. So, could go through a few rounds of cash influx before its over. I tend to stay away from these stocks.
I've been keeping an eye on JAZZ with alerts set for $140. Still think it needs to drop a little further beyond that for most retail investors to be green at the next quarter. ZYNE might have more potential in truly medical based cannabinoid therapeutics, especially since it is synthetic lab-based.
$JAZZ may be a good play here. It got hammered after earnings and is sitting at it's first resistance at close yesterday. Next is $140. Worth a watch. Good company, strong fundamentals and, for now, no competition with their narcolepsy drug. They recently bought out GWPH for their cannabidiniol (spelling?) drug epidiolex - cannabis based epilepsy drug doing quite well in US and EU. Soon to look for more epilepsy indications. Do your own DD.
I also held some GWPH and thought I'd get JAZZ after the sale, but instead I just got cash, also fine w me. I've been considering CGC for a year, looks like now may be a good time to grab a few shares
$JAZZ had great Q2 earnings. Took over GW Pharma in May. But has been falling since June, 23% off ATH then. It also fell 11% today after earnings a day ago. Sitting at 153, nowhere close to its 200 MA of $170-$171. Lost a lot already. Should I load back up on this since this company had very good fundamentals and pipeline?
$JAZZ had great Q2 earnings. Took over GW Pharma in May. But has been falling since June, 23% off ATH then. It also fell 11% today after earnings a day ago. Sitting at 153, nowhere close to its 200 MA of $170-$171. Lost a lot already. Should I load back up on this since this company had very good fundamentals and pipeline?
hmm. Oh. So the strike price isn't in reflection of the current JAZZ share price? I don't get to sell the 12 original share of JAZZ for strike price? and I'd have to cough out $19,990 cash and aforementioned cash?
Then it's like Opposite Day. You receive $100 x strike, and you turn over 12 shares of JAZZ plus the aforementioned cash.
GWPH merged with JAZZ. Before that happened, there were GWPH options. With the merger, GWPH options were turned into JAZZ1 options. It used to be that exercising a GWPH call option resulted in your buying 100 shares of GWPH at the strike price of the option. Now, exercising a JAZZ1 call option results in all of the following three things happening: 1) you buy 12 shares of JAZZ at the strike price of the option 2) you get $(0.036 x market price of JAZZ on a date that is yet to be announced) in cash 3) you get $19,990 in cash You should only worry about this if you already had a GWPH option and it was converted into a JAZZ1 option. If you are considering opening a position in JAZZ1 options, don't. Adjusted options have horrible liquidity.
Anyone know if MJ is going to shift the GW holdings to same % in JAZZ or should I do that manually?
Full explainer here: https://www.reddit.com/r/options/wiki/faq/pages/adjustments Other explainers here: https://www.reddit.com/r/options/wiki/faq#wiki_option_adjustments.3A_splits.2C_mergers.2C_special_dividends.2C_and_more TL;DR - Find the effective date. If that date hasn't come yet, dump your position GWPH options a quickly as you can. If it has already passed, try to get the best price you can by closing out your JAZZ1 options. You should be able to get better than the bid to close out long positions, but you may not be able to get the midpoint, since spreads on non-standard options tend to be wide. If you have ITM calls you can consider exercising, since you probably won't give up much extrinsic value, but be sure you want the deliverable.
I had some long calls in GWPH, which was then bought/merged/not sure what happened. Are my calls now worthless, do they transfer over? The new ticker is JAZZ1 on my calls, but you cant even see to my expiration date when looking at new JAZZ calls. JAZZ is also currently trading at \~$50 less than what GWPH was. Will that impact my calls worth? Kinda lost on what to do. They are showing as worth $1 right now.
I bought some cheap ($5) otm calls on GWPH that expire at the end of Jan 2022. GWPH was just bought by JAZZ, and now my options are for "the right to buy 12 shares of JAZZ and $19,990.00." Clearly I have no idea what I'm doing, so can anybody tell me what that means?
Just had my GWPH shares convert to JAZZ today, thought my broker fucked up at first but then remembered it was a mostly cash deal.
GWPH targeting close of JAZZ acquisition “shortly after” May 5th 🙌🏽
it's most likely a fund buying maybe tim seymour's ETF (he had recently indicated his ETF was approved for swap custody) -- altho if that's true, then RBC being his broker on this side of the border is an interesting development (recall the MSOS etf had been using that ITG broker thru their swap agreement with cowen) RBC itself also has its own MFs, so they could be buying for those as well alternatively, it could just be a very large player taking a position (unlikely tho, because the size is huge [non-diversification]) also, it could be someone covering a very large short position -- altho unlikely finally, i've been mentioning the volume into the MSOS May $39C for the past week or so -- between 2.65 to 2.70 today those are at 3.10 -- the open interest is only about 1400 on those but since apr 16 they've trade about 3300 contracts -- 237 today -- probably more MM tings but I just had some vague flashback to seeing odd volume trading in GWPH contracts (very non-volatile but huge size) a month or so before they were bought out by JAZZ (i'm probably reading too much into it, but something to be ponder)
hmm another 377 MSOS 39C traded today in that same 2.50-2.80 price range this is looking like that trade on GWPH calls a month before JAZZ bought them out
Well I been pretty critical of this company and I have a huge position. I want TBP to do well but right now my biggest two risk factors are their leaking of news issues to their internal members which always causes spikes before any news to the general public and the other is their cash burn rate is at $24 million a year! Yes for a company which is still in FDA phase 2A they are burning $24 million a year. I invested in lot of bio-pharma companies and this is one of the highest burn rate I have seen. If they have success then that be amazing and easily 100-bagger like JAZZ/ GW Pharma, if they fail this shit is going to zero. My advice is If you can afford to lose the money then hold onto the shares, the risk might be worth it.
GWPH is being bought by JAZZ, don’t buy puts on it.
I believe that their only strong competitor is JAZZ/GW in terms of mergers. So if they have a clean break into the US market, potentially $80~$120 by this time next year to year and a half. But what do I know? I am just a retarded ape with bull horns gorilla-glued to my forehead. This is not financial advice 🙃.
The $JAZZ offer, if memory serves, is for each share of $GWPH you will get $220 cash and $20 in $JAZZ shares. You should ask your broker what happens with fractional shares because looks like you’re going to have around 1.5 shares of $JAZZ. TL;DR: You will see your $GWPH shares vanish and $2,640 in cash and 1.5 $JAZZ will appear.
JAZZ is balling out today, earnings last night
everyone chill and try some smooth JAZZ it’s been very refreshing this morning.... huge market slingshot coming soon Way bigger than yesterday I can feel the tingle building in my nutsack
I'm up on GWPH by almost 300%, long term hold for me. I got in around $60 a share. JAZZ is undervalued according to whatever algorithm Yahoo Finance uses, I'm excited about the prospects. I have a buy limit order set but I'm wary I'll miss it with the earnings call if they are up higher than expected. I'm staying on this train long term though.
JAZZ is my only green weed stock today